iXensor Co (ROCO:6734) EBITDA: NT$-39.63 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:6734 iXensor Co Ltd ROCO:6734
55 GF Score
Price NT$6.65
GF Value NT$5.78
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is iXensor Co EBITDA?

iXensor Co ROCO:6734 -2.64% 55 EBITDA is NT$-39.63 Mil as of Dec. 2025. GuruFocus rates ROCO:6734 with a GF Score™ of 55/100 and a GF Value™ of NT$5.78 (Modestly Overvalued). The stock has 5 warning signs investors should review.

iXensor Co's EBITDA for the six months ended in Dec. 2025 was NT$-17.30 Mil. Its EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was NT$-39.63 Mil.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBITDA Growth Rate using EBITDA data.

During the past 10 years, the highest 3-Year average EBITDA Growth Rate of iXensor Co was 15.10% per year. The lowest was 2.70% per year. And the median was 13.50% per year.

iXensor Co's EBITDA per Share for the six months ended in Dec. 2025 was NT$-0.47. Its EBITDA per share for the trailing twelve months (TTM) ended in Dec. 2025 was NT$-1.14.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBITDA per share growth rate using EBITDA per Share data.

During the past 10 years, the highest 3-Year average EBITDA per Share Growth Rate of iXensor Co was 18.40% per year. The lowest was 8.10% per year. And the median was 17.10% per year.

iXensor Co  (ROCO:6734) EBITDA Explanation

EBITDA is a cash flow measure that ignores changes in working capital. EBITDA minus Depreciation, and Amortization (DA) equals Operating Income. Operating Income is profit before interest and taxes. Of course, Interest and taxes need to be paid.

While depreciation and amortization expenses do not need to be paid in cash, assets - especially tangible assets - do need to be replaced over time. EBITDA is not a measure of profit in any sense. EBITDA is a measure of cash generation by a business where the uses of that cash may be more or less discretionary depending on the nature of the business.

The EBITDA of a TV station is largely discretionary. Owners may use much of the EBITDA generated by a TV station as they see fit. The EBITDA of a railroad is largely non-discretionary. Owners must use much of the EBITDA generated by a railroad to replace the physical assets of the railroad or the business will literally fall apart over time.

EBITDA can be thought of as the cash a business generates that is available to:

Add more inventory
Add more receivables
Replace property, plant, and equipment
Add more property, plant, and equipment
Pay interest
Pay taxes
And finally: pay owners

EBITDA is widely used in financial analysis because Depreciation and Amortization are not present day cash expenses.. Depreciation and amortization are the spreading out of the costs of assets over the time in which those assets provide benefits. Today's depreciation and amortization expenses relate to assets bought in the past. The assets being expensed may or may not need to be replaced in the future. And the cost to replace the assets may be more or less than it was in the past. For this reason, the depreciation and amortization expenses a company records in the present year may have no relationship to the actual cash costs needed to maintain its assets in future years.

A company's depreciation expense depends on both its expectations about the assets it owns and its choice of accounting methods. Two companies owning identical assets may have different depreciation expenses because they have different expectations about the useful lives of those assets and because they make different accounting choices.

Analysts use EBITDA to remove this element of personal choice from a company's accounting statements. The use of EBITDA is an attempt to make the results of different companies more comparable and uniform.


Be Aware

Although depreciation is not a cash cost it is a real business cost because the company has to pay for the fixed assets when they purchase them. Both Warren Buffett and Charlie Munger hate the idea of EBITDA because in this calculation, depreciation is not counted as an expense.

EBITDA over Revenue is a good metric for comparing the operating efficiencies between companies because EBITDA is less vulnerable to companies' accounting choices. For this reason, EBITDA is used in ranking the Predictability of Companies. Also Price-to-EBITDA is sometimes used in valuations.


iXensor Co EBITDA Related Terms


iXensor Co EBITDA Historical Data

* Premium members only.

The historical data trend for iXensor Co's EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

iXensor Co EBITDA Chart

iXensor Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only -64.33 2.39 -56.76 -39.32 -39.63

iXensor Co Semi-Annual Data
Dec16 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -25.63 -24.64 -14.68 -22.33 -17.30

ROCO:6734 vs ABT, SYK, MDT: EBITDA Comparison

For the Medical Devices subindustry, iXensor Co's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


iXensor Co EV-to-EBITDA vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, iXensor Co's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where iXensor Co's EV-to-EBITDA falls into.


ROCO:6734
55GF Score
iXensor Co Ltd ROCO:6734
EBITDA is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

iXensor Co's EBITDA for the fiscal year that ended in Dec. 2025 is calculated as

iXensor Co's EBITDA was directly provided by GuruFocus' data source Morningstar. For the fiscal year ended in Dec. 2025, iXensor Co's EBITDA was NT$-39.63 Mil.

iXensor Co's EBITDA for the quarter that ended in Dec. 2025 is calculated as

iXensor Co's EBITDA was directly provided by GuruFocus' data source Morningstar. For the quarter ended in Dec. 2025, iXensor Co's EBITDA was NT$-17.30 Mil.

EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$-39.63 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sometimes companies may have already deducted Depreciation and Amortization from Gross Profit. In this case Depreciation and Amortization needs to be added back when calculating EBITDA.

Frequently Asked Questions Learn more about EBITDA →
What does a EBITDA of NT$-39.63 Mil mean?
iXensor Co (ROCO:6734) has a EBITDA of NT$-39.63 Mil as of Dec. 2025. Ebitda is the difference between operating revenue and operating expenses not including depreciation and amortization. View historical data on iXensor Co.
Is iXensor Co's EBITDA too high?
iXensor Co's current EBITDA is NT$-39.63 Mil. Overall, iXensor Co has a GF Score™ of 55/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does iXensor Co's EBITDA compare to ABT and SYK?
iXensor Co's EBITDA of NT$-39.63 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA for a Medical Devices & Instruments company?
A good EBITDA depends on the Medical Devices & Instruments industry context. However, EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA mean?
A high EBITDA can signal that a stock is expensive relative to its fundamentals. Ebitda is the difference between operating revenue and operating expenses not including depreciation and amortization. View historical data on iXensor Co. iXensor Co's current EBITDA is NT$-39.63 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is iXensor Co stock overvalued right now?
Based on GuruFocus' analysis, iXensor Co (ROCO:6734) is currently considered Modestly Overvalued. The stock's GF Value™ is NT$5.78, compared to a current price of NT$6.65 — trading 15.1% above its estimated fair value. The current EBITDA is NT$-39.63 Mil. iXensor Co's overall GF Score™ is 55/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA calculated?
EBITDA is calculated from a company's financial statements. For iXensor Co (ROCO:6734), the current EBITDA is NT$-39.63 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is iXensor Co (ROCO:6734) Overvalued in 2026?

Based on GuruFocus' analysis, iXensor Co stock appears to be overvalued. The current stock price of NT$6.65 is trading 15.1% above its estimated GF Value™ of NT$5.78. GuruFocus considers iXensor Co to be Modestly Overvalued.

Key valuation signals for ROCO:6734:

  • EBITDA: NT$-39.63 Mil
  • GF Value™: NT$5.78 vs. price of NT$6.65 (15.1% above fair value)
  • GF Score™: 55/100 with 5 warning signs

No single metric tells the full story. See the ROCO:6734 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


iXensor Co Business Description

Address No. 9, Lane 2, Lane 35, Jihu Road, 6th Floor, Neihu District, Taipei, TWN, 11492
iXensor Co Ltd is a Taiwan based company involved in research and development, manufacturing and sales of medical equipment. Its PixoTest technology utilizes the lighting and image sensing module of the smartphone or mobile device to detect the color change reaction on the biochemical test strip. This enables the users to monitor their conditions of diabetes, cardiovascular diseases, women health problems, or infectious diseases.
55GF Score

Get the complete analysis for ROCO:6734

EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$6.65
Price
NT$5.78
GF Value